Randomized, Double Blinded Phase III Trial of Cisplatin and Etoposide Plus Thoracic Radiation Therapy Followed By Nivolumab/Placebo For Locally Advanced Non-Small Cell Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Nivolumab (Primary) ; Cisplatin; Etoposide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 26 Oct 2016 Status changed from not yet recruiting to recruiting.
- 14 Sep 2016 Planned initiation date changed from 1 Jun 2016 to 1 Oct 2016.